Rendered inside a sandboxed frame: scripts, forms and links are disabled. Loading remote images may confirm to the sender that this address exists.

Show headers
From localhost Sun May 24 15:36:27 2026
X-SPAM-SRC: REPO
Return-Path: <4cyuqsrlrc@Kar19569723.onmicrosoft.com>
Delivered-To: markus.naegeli@stafag.ch
Received: from obelix.imp.ch ([157.161.12.5]) by tragicomix.imp.ch with LMTP id uE/JKUTuEmqXJDQAGLljUw:P1 (envelope-from <4cyuqsrlrc@Kar19569723.onmicrosoft.com>) for <markus.naegeli@stafag.ch>; Sun, 24 May 2026 14:25:40 +0200
Received: from obelix.imp.ch ([157.161.12.5]) by obelix.imp.ch with LMTP id uE/JKUTuEmqXJDQAGLljUw (envelope-from <4cyuqsrlrc@Kar19569723.onmicrosoft.com>) for <markus.naegeli@stafag.ch>; Sun, 24 May 2026 14:25:40 +0200
Received: from SEYPR02CU001.outbound.protection.outlook.com (mail-koreacentralazhn150130003.outbound.protection.outlook.com [IPv6:2a01:111:f403:dc0f::3]) (using TLSv1.3 with cipher TLS_AES_256_GCM_SHA384 (256/256 bits) key-exchange ECDHE (P-384) server-signature RSA-PSS (4096 bits) server-digest SHA256) (No client certificate requested) by obelix.imp.ch (Postfix) with ESMTPS id 1F479E39F4 for <markus.naegeli@stafag.ch>; Sun, 24 May 2026 14:25:29 +0200 (CEST)
ARC-Seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none; b=n5123D910kt33HzVBE4n2XGfmVYUDqE7LG4r70nzSY+G4aK/zu8CIJeFyGNqM8+9jsSBPZNt171bxJVe1d8XuTreaDVFWlXx95r7DYt2uWLkCBsJ40gk9njtcR/9iLxOxc3A/pyCIlUzUT9lkDYnFS/y8+x1+vFe7cz7/Wjtu5yd5X8ZZqHtM8xDvJ7PMrtqww9o5DzhbzjGhbkx1MtI/WKJpUNHge7qPOC97mzjXFGrpaAI7K0/950t78PRryhBQbqEvk5CrF/qQA64W7mFhZ6kAKkC785EOGs9y/QjCrS5p+k4G3aueoD2XDlkhk5KuuAHhm8AqnsOpmiPSoOB0g==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=2kxOBJDp5l6SpqBOF0TXWQGcrvQZBR5mKUVa5JHEJWA=; b=UtDszGj7RMa6VJO33QT1en8tTXlbmak9DWEj92mnaJobgfNtLCiiOCPLlv2wuN8MMTYJXNU+UbVNv11jQJQMzoS3TafHDxSIBuLFg3+d6jK/6SG/I7NTH/zYFirkptkVychsUomC8RK5pWMGF/iuwgPsSBZ1CAHDmza9/JirpnTxz1hBXWBuCHITf90BlYJ8BEjs8VkhEp0fy1HIYhXo4Npc3AqnkmI2m6bTgfPKMCCxu9VNcCOgaIxDekqVLy5qLZ1kfXxwZ1dqpmODS5fcxC0x+j99aQGGVPykCBVM+ZQUgUyaZWYSGeevrziq9rSwp6Zux4C3DVLyGhpuNRfdcg==
ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=fail (sender ip is 194.37.82.176) smtp.rcpttodomain=stafag.ch smtp.mailfrom=kar19569723.onmicrosoft.com; dmarc=none action=none header.from=cnnovcp9.com; dkim=none (message not signed); arc=none (0)
Received: from PS2PR03CA0020.apcprd03.prod.outlook.com (2603:1096:300:5b::32) by SEL0PFFFAECFF5E.apcprd01.prod.exchangelabs.com (2603:1096:108:1::5e3) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.48.19; Sun, 24 May 2026 12:25:24 +0000
Received: from TY2PEPF0000AB83.apcprd03.prod.outlook.com (2603:1096:300:5b:cafe::89) by PS2PR03CA0020.outlook.office365.com (2603:1096:300:5b::32) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.71.10 via Frontend Transport; Sun, 24 May 2026 12:25:24 +0000
X-MS-Exchange-Authentication-Results: spf=fail (sender IP is 194.37.82.176) smtp.mailfrom=Kar19569723.onmicrosoft.com; dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=CNNovcp9.com;
Received-SPF: Fail (protection.outlook.com: domain of Kar19569723.onmicrosoft.com does not designate 194.37.82.176 as permitted sender) receiver=protection.outlook.com; client-ip=194.37.82.176; helo=Kar19569723.onmicrosoft.com;
Received: from Kar19569723.onmicrosoft.com (194.37.82.176) by TY2PEPF0000AB83.mail.protection.outlook.com (10.167.253.4) with Microsoft SMTP Server id 15.21.71.7 via Frontend Transport; Sun, 24 May 2026 12:25:23 +0000
To: markus.naegeli@stafag.ch
Date: Sun, 24 May 2026 12:25:22 +0000
MIME-Version: 1.0
List-Unsubscribe-Post: List-Unsubscribe=One-Click
Subject: Breaking: Clinical trials confirm GLPro successLVM-427466
From: "Blood Sugar Watch" <Health@CNNovcp9.com>
Content-Type: text/html; charset="UTF-8"  
Content-Transfer-Encoding: 8bit
Message-ID: <148cbe69-bfe6-4032-b54c-4ab27f023fde@TY2PEPF0000AB83.apcprd03.prod.outlook.com>
X-EOPAttributedMessage: 0
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: TY2PEPF0000AB83:EE_|SEL0PFFFAECFF5E:EE_
X-MS-Office365-Filtering-Correlation-Id: 378a4fec-0fce-4e95-f4d5-08deb98f879e
X-MS-Exchange-SenderADCheck: 2
X-MS-Exchange-AntiSpam-Relay: 0
X-Microsoft-Antispam: BCL:0;ARA:13230040|36860700016|4022899009|7149299003|82310400026|1032899013|34070700014|69100299015|48200799018|61400799027|376014|7049299003|3109299003|3122999024|8096899003|2066899003|4076899003|52005299006|85622059|56012099003|21082099003|18002099003|16102099003|15450700066;
X-Microsoft-Antispam-Message-Info: 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
X-Forefront-Antispam-Report: CIP:194.37.82.176;CTRY:GB;LANG:en;SCL:1;SRV:;IPV:CAL;SFV:NSPM;H:Kar19569723.onmicrosoft.com;PTR:InfoDomainNonexistent;CAT:NONE;SFS:(13230040)(36860700016)(4022899009)(7149299003)(82310400026)(1032899013)(34070700014)(69100299015)(48200799018)(61400799027)(376014)(7049299003)(3109299003)(3122999024)(8096899003)(2066899003)(4076899003)(52005299006)(85622059)(56012099003)(21082099003)(18002099003)(16102099003)(15450700066);DIR:OUT;SFP:1501;
X-MS-Exchange-AntiSpam-MessageData-ChunkCount: 1
X-MS-Exchange-AntiSpam-MessageData-0: OG7ShrQyQNWGCPR6MI1SxuLPAvFh7SkMlshopUu1TEyk4j2olVyref8xq/MsM/Yik+sKN4N40LfptWoaHpjCUtN+3o0YJwZXLMZ7pFl53XQxFPzYbdEBTlpdQ3c7xpWQ31rafYF0cQtoP8a1WF/g4s7ghqgIBJ/p2dQn2P5n52xW4f293kaRuLj5dM2Apd8+Rmko8bGLTcpaM1WReQOAPp6o5g5bgTxcuZhSpvobbLLePYRsvC6fl0k7zdhri3P23wZRgY20JmO+XHLVDoK6hcIvk/PE8cQtEMcbr0FfjE9IaVfohdye9CfBJ0VABgZGn0FhR1BASkFo0Cle16LZYSk6/Hi5u86qj/ABxodoXQo2tua/Now2aoqhd19e09vjjB5msfAbtXapbdO6xMSITZckFWklcwgEmh3ChU/WTtMe+2/Q/WjJGZxZYxIA9kCu
X-OriginatorOrg: Kar19569723.onmicrosoft.com
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 24 May 2026 12:25:23.4699 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 378a4fec-0fce-4e95-f4d5-08deb98f879e
X-MS-Exchange-CrossTenant-Id: b8ecd3c3-c68f-4bfd-9bf7-9219ebe37aba
X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=b8ecd3c3-c68f-4bfd-9bf7-9219ebe37aba;Ip=[194.37.82.176];Helo=[Kar19569723.onmicrosoft.com]
X-MS-Exchange-CrossTenant-AuthSource: TY2PEPF0000AB83.apcprd03.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem
X-MS-Exchange-Transport-CrossTenantHeadersStamped: SEL0PFFFAECFF5E
X-Greylist: Sender IP whitelisted by DNSRBL, not delayed by milter-greylist-4.6.2 (obelix.imp.ch [0.0.0.0]); Sun, 24 May 2026 14:25:30 +0200 (CEST)
X-MS-Exchange-Organization-SCL: 0
X-Spam-Score: -1.15 BAYES_00,DKIM_ADSP_NXDOMAIN,FREEMAIL_FORGED_FROMDOMAIN,FREEMAIL_FROM,HEADER_FROM_DIFFERENT_DOMAINS,HTML_MESSAGE,MIME_HTML_ONLY,RCVD_IN_SWINOG_WHITE,SPF_HELO_PASS,SPF_PASS
X-Scanned-By: MIMEDefang 2.84 on 127.0.1.1
Show raw body
<!DOCTYPE html
    PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">

<head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    <title>Special Health Investigation</title>

    <style type="text/css">
        body {
            font-family: 'Times New Roman', Times, serif;
            background-color: #000000;
            margin: 0;
            padding: 0;
        }

        .main-table {
            width: 100%;
            max-width: 600px;
            background-color: #ffffff;
            margin: 0 auto;
        }

        .red-text {
            color: #cc0000;
            font-weight: bold;
        }

        .cta-button {
            background-color: #cc0000;
            color: #ffffff;
            padding: 16px 28px;
            font-family: Helvetica, Arial, sans-serif;
            font-weight: bold;
            text-decoration: none;
            font-size: 18px;
            border-radius: 3px;
            display: block;
            width: fit-content;
            margin: 0 auto;
        }
    </style>
</head>

<body>

    <table cellpadding="0" cellspacing="0" border="0" width="100%">
        <tr>
            <td align="center" style="padding: 20px 0;">

                <table class="main-table" cellpadding="0" cellspacing="0" border="0">

                    <!-- HEADER -->
                    <tr>
                        <td style="background-color: #000000; padding: 20px; border-bottom: 4px solid #cc0000;">
                            <table width="100%">
                                <tr>
                                    <td align="left"
                                        style="color: #ffffff; font-family: Helvetica, Arial, sans-serif; font-size: 24px; font-weight: bold;">
                                        HEALTH WATCH
                                    </td>

                                    <td align="right"
                                        style="color: #cc0000; font-family: Helvetica, Arial, sans-serif; font-weight: bold;">
                                        SPECIAL REPORT
                                    </td>
                                </tr>
                            </table>
                        </td>
                    </tr>

                    <!-- CONTENT -->
                    <tr>
                        <td style="padding: 30px;">

                            <h1
                                style="font-family: Helvetica, Arial, sans-serif; font-size: 30px; line-height: 1.2; margin-top: 0; color: #111;">

                                <span class="red-text">Blood Sugar Breakthrough?</span>
                                Thousands Are Watching This Controversial Video...
                            </h1>

                            <div
                                style="font-family: Helvetica, Arial, sans-serif; font-size: 14px; color: #666; margin-bottom: 20px;">

                                By <strong>Dr. Michael Reeves</strong> | Medical Correspondent
                            </div>

                            <!-- VIDEO IMAGE -->
                            <a href="https://falokiju.blogspot.com/#4HswVR2984FUdO325cfttzstdyy7820RUFRXZZQACXTRGR591016SUUC1100975W8"
                                style="text-decoration: none; display: block; margin-bottom: 25px;">

                                <div style="border: 1px solid #ddd; padding: 5px;">

                                    <!-- IMAGE -->
                                    <div style="position:relative;">

                                        <img src="https://images.unsplash.com/photo-1576091160399-112ba8d25d1d?auto=format&fit=crop&w=1200&q=80"
                                            width="100%"
                                            style="display:block;"
                                            alt="Blood sugar health">

                                        <!-- PLAY BUTTON -->
                                        <div style="position:absolute;top:50%;left:50%;transform:translate(-50%,-50%);">

                                            <div style="width:90px;height:90px;border-radius:50%;background-color:rgba(204,0,0,0.5);text-align:center;line-height:90px;font-size:42px;color:#ffffff;font-weight:bold;box-shadow:0 0 25px rgba(0,0,0,0.45);">
                                                ▶
                                            </div>

                                        </div>

                                    </div>

                                    <!-- CTA BAR -->
                                    <div
                                        style="background-color:#cc0000;color:#ffffff;padding:12px;text-align:center;font-family:Helvetica, Arial, sans-serif;font-weight:bold;font-size:16px;text-transform:uppercase;">

                                        Click To Watch The Video
                                    </div>

                                </div>

                            </a>

                            <!-- ARTICLE COPY -->
                            <p
                                style="font-family: Georgia, 'Times New Roman', serif; font-size: 18px; line-height: 1.6; color: #333;">

                                <strong>(Atlanta, GA) —</strong>
                                A strange "blood sugar support" presentation is rapidly gaining attention after viewers claimed it helped improve daily energy, cravings, and glucose balance naturally.
                            </p>

                            <p
                                style="font-family: Georgia, 'Times New Roman', serif; font-size: 18px; line-height: 1.6; color: #333;">

                                Experts say these new <strong>GLPro Blood Sugar Capsules</strong>
                                may help support healthy blood sugar levels and metabolic function without extreme dieting.
                            </p>

                            <p
                                style="font-family: Georgia, 'Times New Roman', serif; font-size: 18px; line-height: 1.6; color: #333;">

                                <em>
                                    "I started feeling more balanced within weeks. Less fatigue, fewer crashes, and my morning readings finally started improving."
                                </em>

                                says Linda M., one of the viewers featured in the report.
                            </p>

                            <!-- PRODUCT IMAGE -->
                            <div style="text-align:center;padding:10px 0 25px;">

                                <img src="https://i.8upload.com/image/bfcafb96aa81c5c0/glpro.png"
                                    alt="GLPro Blood Sugar Capsules"
                                    style="max-width:240px;display:inline-block;">

                            </div>

                            <!-- CTA -->
                            <br>

                            <a href="https://falokiju.blogspot.com/#4FNHqn2984MUYy325knfzvclpxe7820MWPZTKWYKLTIMLR591016JKSB1100975I8" class="cta-button">
                                WATCH: The GLPro Presentation →
                            </a>

                        </td>
                    </tr>

                    <!-- FOOTER -->
                    <tr>
                        <td
                            style="background-color:#f4f4f4;padding:20px;text-align:center;font-family:Helvetica, Arial, sans-serif;font-size:11px;color:#888;">

                            Sent by Health Watch Daily.<br>

                            <a href="https://falokiju.blogspot.com/#4mPCof2984rRFX325xvjoqgzucm7820QVUPINHBCUJPLLJ591016SSSN1100975r8">Unsubscribe</a> |
                            <a href="https://falokiju.blogspot.com/#4iissA2984Jwcp325xqkycggybu7820PYCGMXEOARVNFCQ591016ZYAB1100975C8">Terms of Service</a>

                        </td>
                    </tr>

                </table>

            </td>
        </tr>
    </table>

</body>

</html>

Breaking: Clinical trials confirm GLPro successLVM-427466
From "Blood Sugar Watch" <Health@CNNovcp9.com>
To markus.naegeli@stafag.ch
Date 24.05.2026 14:25:22 CEST